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Abstract: Autogenous bone grafting requires a donor site and may lose substantial volume during remod-
eling. Several bone replacement materials (BRMs) are under development to overcome these limitations,
especially for indications for minimally intervention surgeries. The objective of our study was to assess the
potential of an equine collagen cone reinforced with biphasic calcium phosphate (CC-BCP) particles and
deproteinized bovine bone matrix (BBM) coated with polylactic acid, and poly-฀-caprolactone copolymer
(BBM-PCC) and then to compare the outcomes with a deproteinized BBM and an equine CC without
a filler in a sheep sinus grafting model in the Elleven female sheep were selected. Two experimental sites
on each side of the animals were prepared using an extraoral approach for maxillary sinus wall. The
four treatments were performed in each animal through a standardized 10-mm access window. While the
BBM access was covered with a collagen membrane, all other sites were closed with an equine collagen
membrane. All animals were euthanized after 16 weeks. New bone (NB), residual graft particles, and
connective tissue were measured in undemineralized resin-embedded sections. As a result, one sheep did
not survive the surgery. All sites in the remaining 10 sheep healed uneventfully. All CC and BBM-PCC
grafts resorbed and failed to augment the sinuses. BBM and CC-BCP, in contrast, showed some histo-
logic evidence of NB and surgical site augmentation. The NB fraction in the latter two groups accounted
for 10 ± 9 and 4 ± 5%, respectively (p > 0.05). In conclusion, BBM-PCC and collagen cone performed
poorly for sinus floor augmentation, while deproteinised BBM and reinforced collagen cone demonstrated
comparable outcomes.
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Autogenous bone grafting requires a donor site and may lose substantial volume during 
remodelling. Several bone replacement grafting (BRM) alternatives materials are under 
development to overcome these limitations, especially for indications for minimally 
intervention surgeries. OBJECTIVES: To assess the potential of an equine collagen cone filled 
with biphasic calcium phosphate particles (CC-BCP) and deproteinized bovine bone matrix 
coated with polylactic acid and poly-ε-caprolactone copolymer (BBM-PCC) and to compare 
the outcomes to a deproteinized bovine bone matrix (BBM) and an equine collagen cone 
without a filler (CC) in a sheep sinus grafting model. METHODS: An extra-oral approach in the 
maxillary sinus antral wall of 11 female sheep. Two experimental sites on each side of the 
animals were prepared. The four treatments were performed in each animal through a 
standardized 10 mm access window. Whereas the BBM access was covered with a collagen 
membrane, all other sites were closed with an equine collagen membrane. All animals were 
euthanized after 16 weeks. New bone, residual graft particles and connective tissue were 
measured in undemineralized resin-embedded sections. RESULTS: One sheep did not survive 
the surgery. All sites in the remaining ten sheep healed uneventfully. All CC and BBM-PCC 
grafts resorbed and failed to augment the sinuses. BBM and CC-BCP, in contrast, showed 
some histologic evidence of new bone and surgical site augmentation. The new bone fraction 
in the latter two groups accounted for 10% (±9%) and 4% (±5%), respectively (P > 0.05). 
CONCLUSIONS: Deproteinized bovine bone matrix and pure collagen alone are not suitable to 






The posterior maxilla still remains a challenge for dental implant placement due to insufficient 
volume of the residual bone following maxillary sinus pneumatization and alveolar ridge 
resorption1. Sinus floor elevation (SFE) represents a widely used and safe technique used to 
augment the implantation site for optimal implant positioning2,3.  The objective of SFE is 
mainly to create and maintain sufficient space under the sinus membrane to allow for 
osseointegration and prosthetic loading. A variety of grafting materials have been developed 
to serve that purpose and to provide a scaffold to guide the new bone ingrowth.  
Autogenous bone grafts (ABG) are considered osteoconductive, osteoinductive and 
osteogenic. Aa a biocompatible approach, the material poses no risk of transmitting infectious 
disease as well. There are, however, serious drawbacks for the use of ABG. Firstly, the bone 
is harvested from an additional surgical site, which may lead to increased morbidity, patient 
discomfort and additional complications4,5. Secondly, ABG may lose up to 50% of their original 
volume during the first year3,6, which may compromise implant placement. 
A plethora of bone replacement materials (BRM) have been developed during the past two 
decades to overcome some of these shortcomings. Among these, Bio-Oss® (BBM) is a 
deproteinized material of bovine origin that has become widely used in clinical practice, 
shows slow-resorbing turnover rates and is able to maintain the regenerative space even for 
a long period after SFE. There is a convincing body of literature documenting the successful 
use of BBM in SFE7 and this material has often been used as a positive control when new 
products have been tested in preclinical and clinical trials8-11. However, BBM in its particulated 
state may be difficult to manipulate intra-surgically. In the case of the sinus membrane, 
perforations may occur, and the particles may translocate into the sinus space. Furthermore, 
it is challenging to reconstruct complex three-dimensional anatomical structures with 
particulated matter due to a lack of graft stability.  
Novel grafting materials are being developed to overcome the limitation of shape 
maintenance. In our study, we investigated two such materials.  
First, a composite of mineral matrix resembling that of BBM and a degradable synthetic 
polycaprolactone coating (PCC). The resulting BBM-PCC composite material can withstand 
stress, such as shaping with files or pliers, it retains shape after securing to the recipient site12. 
These properties may allow block bone grafting, easier intra-surgical manipulation and 
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complex anatomy reconstruction. 
Second test material, a collagen cone reinforced with biphasic calcium phosphate (BCP) 
granules allows for easy intra-surgical handling and press-fitting into surgical sites without the 
need for precise adaptation. The respective BCP used for this product is a combination of 60% 
hydroxyapatite (HA) and 40% beta-tricalcium phosphate (β-TCP). Whereas the β-TCP portion 
is thought to be resorbed at a faster rate, HA serves as a scaffold for long-term volume 
preservation13. While the use of pure collagen in SFE cases has already been documented in 
animals14 and humans15, the collagen appeared to be fully resorbed before new extra-skeletal 
bone was even formed. The unfilled collagen served in our study as a negative control. 
The objective of our study was to compare novel grafting materials in an ovine model. 
Reinforced collagen, CC-BCP was compared with unreinforced collagen cone alone (CC) as a 
negative control. We also tested polymer coated xenograft and Bio-Oss® (BBM) served as a 
positive control. Histologic and histomorphometric analyses were performed. To the best of 
our knowledge, our work is the first to examine the use of these materials in an animal model 
for maxillary sinus grafting. We hypothesized that the novel grafting materials will show 
healing responses equivalent to the response to the positive control BBM.  
  
2 Materials and Methods 
Experimental animals 
This study followed the ARRIVE guidelines16 for the reporting of in vivo experiments. This 
study was performed in accordance with the New Zealand Animal Welfare Act (1999). The 
Otago Animal Ethics Committee approved the study under protocol number AEC 78-14. 
Eleven 3-4 years old female cross-bred skeletally mature ewes were selected for this study 
from Hercus Taeri Research Unit Breeding Station, New Zealand. All animals had a minimum 
weight of 70 kg and had complete dentitions. Exclusion criteria were: 1) pregnancy or lamb 
at foot 2) infectious pododermatitis (footrot). 
All included animals were tagged, treated for parasites, immunized and relocated to a secure 
pasture before the intervention. They were held in a separate paddock for 48-72 hours prior 
to the surgery and were not allowed oral intake of food and fluids for 24 hours prior to general 





Grafting materials  
Bone replacement materials (BRM) 
Collagen cone (CC): a commercially available resorbable type-I collagen manufactured in a 
cone shape (PARASORB Cone®, RESORBA Medical GmbH, Nurnberg, Germany) containing 
22.4 mg collagen was served as negative (carrier) control.  
Collagen cone reinforced with biphasic calcium phosphate (CC-BCP): Equine collagen cone 
(PARASORB Cone Oss® RESORBA Medical GmbH, Nurnberg, Germany) containing 20 mg of 
non-cross-linked type-I equine collagen reinforced with 2.4 mg biphasic calcium phosphate 
granules (BCP). The phases of BCP were 60% hydroxyapatite (HA) and 40% beta-tricalcium 
phosphate (β-TCP).  
Bovine bone matrix coated with synthetic polycaprolactone (BBM-PCC): Porous rigid cubes 10 
x 10 x 10 mm of the composite material (Industrie Biomediche Insubri SA CH-6805 Mezzovico-
Vira, Ticino, Switzerland).  Bovine bone matrix (BBM):  
Particles of commercially available pure deproteinized bovine bone xenograft (Bio-Oss®, 
Geistlich Pharma AG, Wolhusen, Switzerland) 0.25 – 1 mm in size were used as positive 
control. 
 
Barrier membranes  
Equine collagen membrane (ECM): Resorbable equine type-I collagen membrane (PARASORB 
RESODONT®, RESORBA Medical GmbH, Nurnberg, Germany); used to cover the access 
window of CC-BCP, CC and BBM-PCC-grafted sites.  
Porcine collagen membrane (PCM): Resorbable porcine type-I collagen membrane (Bio-
Gide®, Geistlich Pharma AG, Wolhusen, Switzerland), used to cover the access window of 
BBM-grafted sites.  
 
Study design and surgery 
Each animal received all four treatment modalities, i.e. one negative control site (CC), two 
test sites (CC-BCP and BBM-PCC) and one positive control site (BBM). The grafting sites were 
randomly allocated prior to the intervention for each animal according to a pre-defined 
random list. Every subsequent animal received a different pre-allocation of the materials. 
General anaesthesia was induced by intravenous infusion of thiopentone 20mg/kg and 
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maintained with 1-2% halothane. Surgical sites were infiltrated with a local anaesthetic: 2 X 
2.2ml of mepivacaine 2%, with adrenaline concentration 1:100000. 
The surgical approach of Haas et al. (1998) 17 was used with an extra-oral access to the antral 
wall (FIGURE 1). Firstly, a para-median oblique sagittal skin incision about 6 cm in length 
inferior to the lower eyelid was created to the subdermal level, using an electrosurgical unit. 
A circular bone window was demarcated in the anterior part of the exposed maxilla without 
perforating the full thickness of the bone, using a 10 mm trephine. The central part of the 
window was separated with a piezo-surgical device using the OT5 round diamond-coated tip. 
The bone from the central portion of the osteotomy was carefully detached from the 
Schneiderian membrane (SM). The SM was elevated superiorly and distally using sinus 
membrane dissectors. The second osteotomy was made 8 mm posteriorly to the first one. 
Two osteotomies on each side of the animal were made, resulting in four experimental sites 
per animal (FIGURE 1). If SM perforation occurred, a Loma-Linda pouch technique with barrier 
membrane was planned for repair18. For all SM repairs, ECM membranes were used.  
The pre-allocated material was placed under the elevated SM as follows:  
CC and CC-BCP were transferred into the surgical site straight from their sterile packages. The 
BBM-PCC block was mixed with saline and particulated. BBM was also mixed with saline prior 
to grafting.  
After grafting, a barrier membrane was placed over the access window with all its edges 
supported by at least 5 mm of bone. Muscle and fascia layers were repositioned and sutured 
using resorbable polyglycolic acid sutures. The dermis was sutured with synthetic resorbable 
monofilament sutures. Immediate postoperative pain control was achieved by local 
infiltration of 1 ml of bupivacaine hydrochloride 0.5%, with adrenaline 1:200000. Halothane 
was stopped, and the animal was extubated and moved to a separate individual recovery area 
monitored by a veterinary technician for a few hours.  
For three days following the surgery, the sheep were kept separately and received 
subcutaneous injections of 5ml carprofen and 1ml/15kg trimethoprim once a day. After three 
days of intensive postoperative care, all animals were returned to pasture and grazed freely 
for the duration of the healing period. Sequential weight measurements were taken to 
confirm normal recovery.  
After 16 weeks of healing, the animals were sacrificed with an overdose of halothane. The 
external carotid arteries were exposed, cannulated and perfused with 1 L of normal saline 
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and 1.5 ml of 5000 IU heparin. After the overdose, animals were perfused with 2 L of 10% 
neutral buffered formalin (NBF) through the carotid arteries. The maxillary sinus specimens 
were retrieved by block resections, rinsed with water, and placed into NBF. 
 
Histologic preparation  
Non-decalcified resin-embedded tissue sections were prepared using the protocol originally 
described by Donath and Breuner (1982)19 and later modified by Duncan (2005)20. The 
trimmed samples were dehydrated in graded series of ethanol and infiltrated by methyl meta-
acrylate. The resin blocks were sliced into sequential coronal 700 µm sections using a 
precision table-top microtome. Two coronal sections representing the central area of the 
grafted site were chosen for further processing. These sections were ground and polished to 
80-100 µm using a rotary grinding machine and stained with a mixture of one-part MacNeal’s 
tetrachrome (methylene blue, azure II and methyl violet) and two-parts toluidine blue as 
described by Schenk (1984)21. High-resolution microphotographs were obtained with a light 
microscope and an imaging system (Micropublisher 5.0 RTV, Qimaging, Surrey, BC, Canada) 
at a 10-fold magnification. Each section was scanned as series of 20-80 images (depending on 
the size of the section), which were then stitched together into a single panoramic scan, using 
a montaging software (Volocity 5.2.0, Improvision, USA; Autopano Pro 2.5.2, Kolor, USA).  
 
Histomorphometric analysis 
The area between the sinus wall to the Schneiderian membrane was included in the region of 
interest (ROI) for analysis. The following guidelines (FIGURE 2) were implemented when 
outlining ROI: 1) a straight line was drawn tangentially to medial margins of the repairing sinus 
walls; 2) two perpendicular lines tangent to the most distal hard tissue formations (graft or 
new bone) in the augmented area were marked; 3) a third line following the Schneiderian 
membrane connected the previously charted perpendicular lines. 
McNeal’s tetrachrome differentially stains newly forming bone, mature bone and grafted 
mineral due to variations in glycosaminoglycan content. The differences in staining were used 
to section the digital images into areas occupied by graft, new bone and connective tissue 
(FIGURE 3) using a combination of colour thresholding and the manual tracing tools of an 
image analysis computer software (G. Landini, Colour threshold plugin and tracing tool for 
ImageJ version 1.51n, National Institute of Health, USA). The outcome variables were defined 
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as follows:  
• Residual graft (RG) = percentage of ROI occupied by the residual graft particles.  
• New bone (NB) = percentage of ROI occupied by the newly formed extra-skeletal bone  
• Connective tissue (CT) = percentage of ROI occupied by soft tissue and marrow spaces 
Due to obvious difference in the physical and histologic appearance of BBM, BBM-PCC and 
CC-BCP, operator and examiner blinding was not practical. The consistency of measurements 
of histomorphometric analysis was assessed using the help from the examiner that did not 
otherwise participate in this study. Ten specimens of BBM and CC-BCP were randomly 
selected, then for each specimen the examiners assessed the total augmented area (ROI) and 
the fraction occupied by NB, RG and CT in the pre-defined area of interest. 
 
Statistics and calibration 
Two sections per surgical site were used to reduce a possible bias of having a single 
mispositioned section. The average between these two images was used for statistical 
analysis as the representative mean value for the respective grafted site. Mean values and 
standard deviations were calculated for all outcome variables. Since non-parametric 
distributions were assumed within groups, Wilcoxon signed rank test was used to compare 
between groups using individual animals as a statistical unit. Differences were considered as 
being statistically significant when two-sided p-values were < 0.05. All statistical analyses 
were performed with SPSS® 23 software (IBM Corporation, Armonk, New York, United 
States). 
For intra- and inter-examiner consistency, intraclass correlation coefficient (ICC) of 
assessments was calculated using two-way mixed model and absolute agreement type. As 
suggested by Cicchetti (1994)22, ICC’s below 0.7 were seen as unacceptable; ICC’s between 
0.7 and 0.79 were seen as fair; ICC’s between 0.8 and 0.89 were seen as good; ICC’s above 0.9 
were seen as excellent. 
 
3 Results 
The first animal receiving surgical intervention did not recover from the general anaesthesia 
and had to be euthanized. The grafted sites from the euthanized animal were excluded from 
the analysis. The study sample therefore consisted of a total of 10 animals (FIGURE 4). All 
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other animals recovered from the procedure without any complications and all surgical sites 
healed uneventfully. Thus, twenty sinuses, comprising 40 grafted sites, were retrieved and 
processed for histologic and histomorphometric analysis. 
 
Descriptive histology 
The healing of the epidermis, dermis, muscle and fascia of the antral wall was complete for 
all experimental sites. The mucosal lining of the sinus wall, the Schneiderian membrane (SM), 
presented as a single layer of pseudostratified columnar ciliated epithelium with multiple 
goblet cells. The lamina propria was highly vascular with multiple well-stained mucinous 
glands. Histologically, the SM appeared not interrupted in all specimens, except in one CC-
BCP site. Interestingly, no SM perforation in this site was detected clinically during the 
intervention. In other sites, four SM perforations with a diameter of ≤ 5 mm were detected 
during the surgery in two animals (TABLE 1). Notably, in three of these repaired sites, the 
grafting material (BBM, CC-BCP and BBM-PCC) disappeared completely, and no extra-skeletal 
bone formed during healing. 
Bone repair of the surgical access window was evident in all specimens (FIGURE 5). The newly 
formed bone could be observed on both, the antral and facial sides of the original cortical 
bone plates. In 8/10 BBM, 7/10 CC-BCP, 8/10 CC, and 2/10 BBM-PCC grafted sites, the original 
cut edges were impossible to locate due to remodelling and replacement by the new bone 
structures.  
In 9/10 BBM specimens and 7/10 CC-BCP specimens, a successful augmentation was evident 
(FIGURE 5). The NB appeared to be in direct contact with BBM and CC-BCP particles. The BBM 
particles were irregularly distributed, and some were incorporated into repairing bone walls, 
whereas the CC-BCP particles were more tightly packed in the centre of the augmented site.  
All CC and 9/10 BBM-PCC specimens failed to demonstrate any signs of augmentation (FIGURE 
5). Therefore, histomorphometric analysis was performed only for the BBM and CC-BCP 
groups. Residual graft appeared to be in direct contact with bone in only one specimen of 
BBM-PCC (FIGURE 6). This specimen demonstrated osteoclastic resorption lacunae on the 
surface of the residual graft facing the connective tissue (FIGURE 6). 
 
Histomorphometry 
Connective tissue occupied most of the ROI for both, BBM (72%) and CC-BCP (82%) and the 
10 
 
residual grafting material occupied similar areas for BBM (17%) and CC-BCP (18%). BBM 
grafted sites demonstrated on average more than twice as much new bone in the ROI (10% 
for BBM versus 4% for CC-BCP) but statistical significance was not reached (p = 0.11). The 
standard deviation suggested a large variability of the outcomes within groups. The areas of 
new bone, residual graft, and connective tissue are presented in TABLE 2. 
Ten specimens of BBM and CC-BCP were randomly selected and re-analysed by a second 
independent researcher and ICC for intra- and inter-examiner consistency was calculated. 
Excellent correlation22 was demonstrated for all measurements (TABLE 3).  
 
4 Discussion 
The present study aimed to test two new bone substitute materials for sinus grafting against 
a well-studied deproteinized particulate xenograft, which served as a positive control. Pure 
collagen as a sponge was used as a negative control. The study objective was to analyse the 
outcomes of this sinus grafting histologically and histomorphometrically, using a well-
established sheep animal model 8,17.  
In this study, as expected, the negative control collagen cones (CC) completely disappeared 
from all but three experimental sites, where the degenerated remnants of the material were 
still present within the sinus submucosa.  
The rationale of placing a collagen cone into fresh extraction sockets is mainly to stabilize the 
blood clot. Collagen resorbs within 4-8 weeks after implantation in rats 23,24. As a successful 
sinus floor augmentation requires a space maintenance beneath the elevated Schneiderian 
membrane, which can be maintained over a longer period to permit new bone formation in 
a pre-formed space, we may conclude that the resorption of CC material occurred too rapidly, 
leading to the premature collapse of this space.  
Ahn and co-workers (2011) 15 also used bovine collagen plugs for sinus floor elevation through 
a lateral approach in a clinical case series study on thirteen patients. In their study, the grafted 
sites failed to demonstrate clinically relevant new bone formation, which corroborated our 
findings.  
The two novel grafting materials behaved quite differently in our animal model. 
Unexpectedly, BBM-PCC particles completely disappeared from most sites after 16 weeks 
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post-implantation, with a resulting collapse of the Schneiderian membrane and no new extra-
skeletal bone formation. It remains unclear why the BBM-PCC grafting material underwent 
such a quick resorption. We may hypothesize that an increased pH or temperature of the 
inflamed healing wound area may have accelerated hydrolysis of the polymer coating, leading 
to inflammation-driven resorption of BBM-PCC in the earlier stages of wound healing. 
Furthermore, the bovine-derived deproteinized matrix of BBM-PCC is treated via acid attack 
at a low temperature25. Bone xenografts prepared using low-temperature deproteinization 
without sintering are therefore thought to be resorbed more rapidly26. This may have also 
contributed to the quick resorption and disappearance of the BBM-PCC in our model.  
To date, only limited amount of empirical data has been gathered concerning the resorption 
of a specific formulation of BBM combined with PLA-PCL complex. The manufacturer of BBM-
PCC used a mathematical model for predicting the resorption rate of the material and stated 
it should be adequate for slow resorption and creeping substitution by the bone 12. Two small-
scale case series studies in humans provided some evidence of such substitution with the new 
bone fraction reaching 67% of the specimen 27,28. The results from our study, however, could 
not support the results of these reports. 
The degradation of PLA and copolymers is well documented for both in vitro and in vivo 
experiments 29. The addition of PCL to the composition is thought to slow down the rate of 
resorption of PLA and to improve its mechanical properties 30. As humans and animals lack 
the enzyme to degrade PLA and PCL, the resorption proceeds via hydrolysis, rather than 
enzymatic degradation 31. The hydrolysis of these materials is complex and is still not 
completely understood. During degradation, they are thought to lose fragments from the 
surface; these fragments break up into even smaller oligomers that are soluble in the extra-
cellular matrix 31. However, unpredictable bulk hydrolysis and quick resorption can sometimes 
be registered in-vivo for certain PLA-PCL co-polymers 32. 
In a clinical case series, Scarano et al. (2006) 33 performed SFE in 94 patients with nine 
different grafting materials, including Bio-Oss®, autogenous bone and poly-glycolic-poly-lactic 
acid copolymer (PLA-PGA). Biopsies were retrieved during implant placement in the grafted 
sites after 6 months. On histologic examination, this polymer appeared to be substituted by 
the newly formed bone. The latter constituted on average to 33% ± 2.1%, marrow spaces 59% 
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± 2.3%, while residual PLA-PGA occupied 3% ± 2.1% of augmented sites. Apparently, not all 
degradable polymers will be suitable for SFE, whereas some may be efficient.  
New bone was found around the particles of both the positive control Bio-Oss® (BBM), and 
the novel reinforced collagen graft material, Cone Oss® (CC-BCP). The NB was deposited 
directly on the surface of the particles with no interposing tissues, confirming that BBM and 
CC-BCP were both biocompatible and showed osteoconductive properties. The type of NB 
was mostly lamellar, suggesting that the grafted site was relatively mature. In a recent study 
using the same model8, grafted sinuses with BBM demonstrated a similar histologic 
appearance after 12 weeks of healing. Alayan et al. (2016)34 documented an increase in the 
lamellar bone fraction from 8 to 16 weeks of healing.  
The newly formed bone occupied 9% of the region of interest (ROI) in the sites grafted with 
BBM. A previous study by our institution using Biomet 3i Endobon® (DBBM) in the sheep sinus 
also showed that 9.5% of the ROI was filled with new bone after 16 weeks 35. However, these 
findings contrast with publications by other research groups. In a recent study using a similar 
sheep model, the new bone area with BBM was reported to be much higher after 16 weeks 
of healing – and reached up to 50% ROI34. In human trials, the amount of newly formed bone 
during the first year in cases treated with maxillary sinus augmentation using BBM varies from 
8% to 42% 36,37.   
The sites grafted with CC-BCP demonstrated only a mean value of 4% of new bone formation 
within the ROI. No other animal or human trials have investigated formulations that match 
CC-BCP (an alloplast consisting of 40:60% TCP:HA in a collagen cone) so far. However, a similar 
graft material composed of biphasic 40:60% TCP:HA but without the collagen matrix has been 
documented in human 10,38,39 and animal trials 9,40. The NB area was reported to be between 
20-30%, which contradicts our findings. The collagen matrix of the composite materials is 
unlikely to interfere with new bone formation 41-43.  
Whilst the NB fraction is an important histologic outcome, its clinical significance is not 
established yet. The mineralized content of bone in posterior maxillary sites in humans has 
been demonstrated to be 28% 44. In the present study, the sites grafted with BBM and CC-BCP 
therefore rather corresponded to a bone of poorer quality. Pull-out tests correlated increased 
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bone fraction with increased pull-out forces 45. It is not known, however, what percentage of 
vital bone must be formed in the grafted site to result in improved survival of the implants 
under clinical conditions 3.  
We consider that our animal model was appropriate to examine novel grafting materials. 
Sheep sinus anatomy is considered adequately comparable to that of humans in 
otolaryngology 46 and surgical training 47. Estaca et al. (2008) performed a fresh sheep head 
dissection and stated that the lateral wall of the sheep sinus is relatively thin and easily 
trephined, resembling a situation in the human edentulous posterior maxilla. Ovine bone 
shows considerable resemblance to human bone in terms of macrostructure 49 and chemical 
composition 50.  
The animals in this study were killed after 16 weeks of healing. It is possible that more NB 
could have been formed in the grafted sites after more time. The 16-week healing period was 
chosen to produce comparable data with other groups, which used sheep as SFE model as 
well 34,51,52. The healing rate in sheep seems faster as compared to humans 53. In a critical-size 
defect model, Duncan (2005) has estimated that a 16-week healing period of healing in sheep 
corresponds to a 21-week healing time in humans, which is an acceptable healing time for 
sinus floor elevation. 
One of the limitations of our study is that we used a single time-point for all animals. While 
providing more power to the study, this did not offer any insights as to the pace of graft 
consolidation and resorption. We are unable to comment on whether the BBM or CC-BCP 
reached the limit of their potential or whether they would have retained the augmented 
volume after a longer follow-up period. Furthermore, we acknowledge that the extra-oral 
approach in this model and the use of a standard amount of the grafting material for every 
site, regardless of surgical anatomy, are not representative of clinical practice of SFE in human 
patients. Given the study limitations and the inherently limited applicability of animal 
research to humans, care should be exercised when applying the outcomes of the present 
study to clinical practice.  
In this study, we used an unrestored and unloaded model. We recommend that subsequent 





After 16 weeks healing, the equine collagen cone and bovine bone matrix – polymer 
composite graft disappeared from the grafted sites, the Schneiderian membrane collapsed 
and no extra-skeletal bone was formed in the respective augmented sites. In contrast, pure 
bovine bone matrix (Bio-Oss®) and the novel graft material, collagen cone reinforced with 
biphasic calcium hydroxide produced some augmentation and new extra-skeletal bone 
formation. Both later materials resulted, however, in a comparatively low new bone fraction, 
which may be a result of the specific animal model used or the insufficient time allocated for 
graft consolidation. Although on average twice as much new bone formed for Bio-Oss® than 
for reinforced collagen cone, the results were highly variable and not statistically significant. 
We conclude that novel reinforced collagen cone results in equivalent osseous healing to Bio-
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7 Figures – legends 
 
FIGURE 1. Surgical procedure. A – Surgical sites location. B – Soft tissue dissection. C – 
Osteotomy preparation, the surgical window is detached by the piezo-surgical device. D – 
Grafting materials in place (black arrow – bovine bone matrix (BBM), empty arrow – collagen 
cone reinforced with biphasic calcium phosphate). E – porcine collagen membrane applied to 
the BBM site. F – Primary closure of the soft tissues. 
 
FIGURE 2. Selection of the region of interest (ROI). (a) – straight line tangent to medial margins 
of repairing sinus walls. (b) – two perpendicular lines to (a) and tangent to the most distal 
residual graft particles in the augmented area. (c) – third line following the Schneiderian 
membrane and connecting the (b) lines.  
 
FIGURE 3. Sectioning of the image for the histomorphometric analysis. A – microphotograph 
of the ROI. B – the same image sectioned into residual graft (yellow), new bone (blue) and 
connective tissue (uncoloured) 
 
FIGURE 4. Study design 
 
FIGURE 5. Montaged microphotographs of representative histological specimens. A – bovine 
bone matrix (BBM). The Schneiderian membrane is elevated. The newly formed bone is in 
direct contact with residual graft particles; B – collagen cone reinforced with biphasic calcium 
phosphate (CC-BCP). The residual graft particles are tightly packed underneath the elevated 
Schneiderian membrane. The collagen matrix is completely resorbed and replaced by 
connective tissue. New bone is in direct contact with the residual graft particles; C – BBM 
coated with synthetic polycaprolactone coating (BBM-PCC). The Schneiderian membrane is 
collapsed. There is no evidence of the residual grafting material; D – pure equine collagen 
graft (CC). The Schneiderian membrane is collapsed. No evidence of the residual grafting 
material is present. 
 
FIGURE 6. The most successful site grafted with BBM coated with synthetic polycaprolactone 
coating. A – overview. The residual graft and bone occupy minimal area. The Schneiderian 
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membrane (empty arrows) is collapsed. The area inside the red rectangle is magnified in 
figure B. B – the residual graft (g) is in direct contact with new bone (b). Multiple resorption 








































































Table 3. Interexaminer and intraexaminer agreement  
 
 
 
